Andrew O Todd, DO | |
3927 Rucker Ave, Everett, WA 98201-4833 | |
(425) 259-0966 | |
Not Available |
Full Name | Andrew O Todd |
---|---|
Gender | Male |
Speciality | Pediatric Medicine |
Experience | 27 Years |
Location | 3927 Rucker Ave, Everett, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720046873 | NPI | - | NPPES |
006772 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | OP00002108 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Everett Clinic Pllc | 6406752153 | 552 |
News Archive
Exelixis, Inc. today announced that the European Commission has approved COMETRIQ (cabozantinib) for the treatment of adult patients with progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma (MTC).
Ranbaxy Pharmaceuticals announced tentative approval from the U.S. Food and Drug Administration to manufacture and market Topiramate Tablets, 25 mg, 100 mg, and 200 mg. Total annual market sales for Topiramate were $1,184 million with sales of these three strengths of tablets totaling $1,129 million.
Massachusetts businesses and most of the state's health insurers on Wednesday announced the formation of the Coalition for Affordable Health Coverage, a lobbying group that will work to control rising health care costs in the state and prevent cost-shifting to employers, the Boston Globe reports.
Pharmaxis, Inc. today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific billing code, or J-code, for ARIDOL (mannitol inhalation powder) Bronchial Challenge Test Kit.
› Verified 4 days ago
Entity Name | The Everett Clinic Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831186766 PECOS PAC ID: 6406752153 Enrollment ID: O20031211000922 |
News Archive
Exelixis, Inc. today announced that the European Commission has approved COMETRIQ (cabozantinib) for the treatment of adult patients with progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma (MTC).
Ranbaxy Pharmaceuticals announced tentative approval from the U.S. Food and Drug Administration to manufacture and market Topiramate Tablets, 25 mg, 100 mg, and 200 mg. Total annual market sales for Topiramate were $1,184 million with sales of these three strengths of tablets totaling $1,129 million.
Massachusetts businesses and most of the state's health insurers on Wednesday announced the formation of the Coalition for Affordable Health Coverage, a lobbying group that will work to control rising health care costs in the state and prevent cost-shifting to employers, the Boston Globe reports.
Pharmaxis, Inc. today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific billing code, or J-code, for ARIDOL (mannitol inhalation powder) Bronchial Challenge Test Kit.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Andrew O Todd, DO Po Box 5127, Everett, WA 98206-5127 Ph: (425) 259-0966 | Andrew O Todd, DO 3927 Rucker Ave, Everett, WA 98201-4833 Ph: (425) 259-0966 |
News Archive
Exelixis, Inc. today announced that the European Commission has approved COMETRIQ (cabozantinib) for the treatment of adult patients with progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma (MTC).
Ranbaxy Pharmaceuticals announced tentative approval from the U.S. Food and Drug Administration to manufacture and market Topiramate Tablets, 25 mg, 100 mg, and 200 mg. Total annual market sales for Topiramate were $1,184 million with sales of these three strengths of tablets totaling $1,129 million.
Massachusetts businesses and most of the state's health insurers on Wednesday announced the formation of the Coalition for Affordable Health Coverage, a lobbying group that will work to control rising health care costs in the state and prevent cost-shifting to employers, the Boston Globe reports.
Pharmaxis, Inc. today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific billing code, or J-code, for ARIDOL (mannitol inhalation powder) Bronchial Challenge Test Kit.
› Verified 4 days ago
Sandra Liu, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-259-0966 | |
Dr. Leah E Hastings, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1818 121st St Se, Everett, WA 98208 Phone: 425-357-3300 Fax: 425-357-3317 | |
Dr. Amy Wang Johnson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1424 Broadway, Everett, WA 98201 Phone: 425-789-2000 Fax: 425-789-2096 | |
Ashaini Kadakia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2930 Maple St, Everett, WA 98201 Phone: 425-261-1500 Fax: 425-261-1515 | |
David Luba, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1818 121st St Se, Everett, WA 98208 Phone: 425-357-3302 | |
Judith H. Kuo, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 12800 Bothell Everett Hwy, Suite 190, Everett, WA 98208 Phone: 425-316-5160 Fax: 425-316-5163 | |
Dr. Ruth Ann Parish, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1424 Broadway, Everett, WA 98201 Phone: 425-789-2000 Fax: 425-789-2096 |